blog

2021: A Look Inside Our Crystal Ball (part two)

By Elizabeth Gargill on Tue, Dec 22, 2020 | 7 min read

 

For part two of our Crystal Ball series, we asked a few more of our industry experts to comment on the clinical research landscape and to share their predictions for 2021.

Rob Laurens, Principal, RSG Services

 

Do you think a lot of the travel services rapidly deployed in response to COVID-19 will remain in effect? Will they become part of the standard offering?

Undoubtedly, many of the extraordinary support services deployed as a means to directly respond to the impact of the COVID-19 pandemic on clinical trial participant travel not only will remain available after the distribution and anticipated positive impact of vaccines, but also will be enhanced to serve the needs of a redefined approach and capabilities for clinical trial conduct by sponsors and CROs. 

Topics: BBK Worldwide, Patient Engagement, Patient Travel, Patient Experience, Patient Enrollment, Rob Laurens, Aaron Fleishman, Clinical Trial Patient Travel, Decentralized Trials, Virtual, Hybrid Trials, 2021 Predictions, 2021

2021: A Look Inside Our Crystal Ball (part one)

By Elizabeth Gargill on Mon, Dec 21, 2020 | 5 min read

 

As part of our Crystal Ball series, we asked BBK Worldwide President Matt Kibby to comment on the clinical research landscape and to share his predictions for 2021.

Matt Kibby, Principal, President

Is there a particular trend that you expect to have a significant impact on the industry in the coming year?

 

With COVID-19 dominating the headlines for much of 2020, one might expect that a key development for clinical R&D in 2021 will be the continued integration and expansion of services that support the hybridization / decentralization of clinical trials. Keeping trial participants – who tend to be older and at greater risk for complications from COVID-19 – away from clinical trial sites not only reduces the risk of SARS-COV-2 infection, but also offers the possibility of enrichment of the clinical trial experience; reduces the overall visit and expense burden for patients; and, moreover, reduces the trial burden on clinical trial site healthcare professionals.

Topics: BBK Worldwide, Patient Engagement, Patient Travel, Patient Experience, Patient Enrollment, Matt Kibby, Clinical Trial Patient Travel, 2021 Predictions, 2021, Underserved Populations

Survey Reveals Site Perspectives on Clinical Trial Services

By Elizabeth Gargill on Tue, Dec 1, 2020 | 2 min read

What do doctors and nurses think about solutions designed to make clinical trials easier to conduct? Are they helpful? Do they alleviate burdens? And which ones do they prefer?

In this special Pharma15 Live! segment, BBK Worldwide industry experts Matt Kibby and Aaron Fleishman discuss recent Study Voices survey results that shed light on this topic. They examine doctor and nurse perspectives on services designed to provide support in conducting clinical trials — including services for virtual, hybrid, and decentralized clinical trials.

“We were looking at whether or not doctors and nurses at sites that were conducting clinical trials would appreciate different types of services that assist with their ability to conduct them."

-Matt Kibby, Principal, President, BBK Worldwide

Topics: Clinical Trials, Pharma15 Live!, Study Voices, COVID-19, Matt Kibby, Aaron Fleishman, Decentralized Trials, Virtual, Study Voices 2020, Surveys, Site Voice, Hybrid Trials

Clinical Trial Innovation: More Important Now Than Ever

By Elizabeth Gargill on Thu, Nov 19, 2020 | 2 min read

 

Clinical Trial Innovation: More Important Now Than Ever

A new survey gives voice to the healthcare consumer in the wake of COVID-19 and highlights the importance of innovation in clinical trial patient enrollment and engagement.

DOWNLOAD NOW

New data provides clinical trial sponsors with the information they need to confidently embrace innovative solutions in response to COVID-19. The Study Voices 2020* survey reflects perspectives from patients, medical professionals, and members of the pharmaceutical industry. The findings reveal shifts in attitudes and behaviors since the onset of COVID-19 – insight that clinical trial sponsors can leverage for enrollment and engagement efforts, including for hybrid and virtual study models.

Topics: Patient Engagement, Patient Experience, Healthcare Consumer, COVID-19, International Clinical Trials, Patient Voice, Telehealth, Elizabeth Gargill, Study Voices 2020, Surveys, Site Voice, Publications

In a new Outsourcing-Pharma interview, Elizabeth Gargill discusses why clinical trial innovation matters more now than ever

By BBK Worldwide on Fri, Oct 23, 2020 | 4 min read

 

Earlier this week, Elizabeth Gargill went one-on-one with Outsourcing-Pharma, discussing findings from BBK's recent Study Voices survey that reveal shifts in healthcare consumer attitudes and behaviors since the onset of COVID-19. In this in-depth interview, Elizabeth discusses why clinical trial innovation is more important now than ever before and how clinical trial sponsors can leverage the survey findings to enhance their enrollment and engagement efforts.

Topics: Patient Engagement, Clinical Trials, Study Voices, Healthcare Consumer, Survey, Clinical Trial Innovations, Clinical Trial Enrollment, Study-life Balance, Outsourcing-Pharma, Telehealth

Why It’s Now Easier than Ever to Engage with Patients Wherever They Are

By Elizabeth Gargill on Thu, Oct 15, 2020 | 4 min read

 

Clinical trial sponsors now have access to several new solutions that make it possible to engage with patients wherever they are now more important than ever before as trials shift to hybrid and decentralized models.

Sponsors can transform their clinical trials with engagement solutions that prioritize patient care and convenience, helping maintain study momentum during COVID-19 and beyond.

Topics: Apps, Patient Experience, Study Voices, Patient Reimbursement, Patient Portals, Clinical Trial Innovations, COVID-19, Medication Delivery, In-home Nurse Visits

Ready, Set, Go Virtual!

By Elizabeth Gargill on Tue, Oct 6, 2020 | 2 min read

 

Ready, Set, Go Virtual!

New virtual engagement solutions are delivering patients the convenience and immediacy they want in their healthcare experience. Solutions that support decentralized or hybrid trials, like BBK’s virtual RSG® Card, are helping to remove some of the barriers to clinical trial participation that patients cite as the most challenging.

As a matter of fact, in BBK's recent Study Voices 2020 survey, patients selected "immediate reimbursement for study-related expenses" as the most important solution influencing their decision to participate in a clinical trial.

Topics: Patient Engagement, Patient Experience, Study Voices, Patient Reimbursement, RSG Card, Clinical Trial Innovations, Decentralized Trials, Virtual, Stipends

Study Voices 2020: Survey Findings Vol. 1

By Elizabeth Gargill on Tue, Sep 29, 2020 | 2 min read

 

During the last two weeks of August we surveyed more than 1,200 healthcare consumers, medical professionals, and members of the pharmaceutical industry for their perspectives on topics impacting today's healthcare consumer.

The findings provide a unique look at current attitudes and behaviors that inform the patient experience. They provide clinical trial sponsors with a snapshot of a critical moment in time when we're seeing the rise of telehealth, the adoption of decentralized and hybrid trials, and heightened awareness of clinical research. They also reveal new opportunities and challenges ahead for clinical trial enrollment and engagement.

Download Now

Topics: Patient Experience, Study Voices, Healthcare Consumer, Survey, Clinical Trial Innovations, COVID-19, Telehealth

BBK Worldwide Showcases Its Commitment to Innovation at DPharm 2020

By Aaron Fleishman on Fri, Sep 18, 2020 | 2 min read

 

DPharm. It's one of my favorite conferences that I look forward to each year. This year we will be virtual September 22-23, but still the same great energy and excitement. DPharm is a standout event that challenges and reports on innovation, with the goal of shaking up the way we conduct clinical trials so that we can reduce patient / physician burden and create greater efficiencies.

Topics: Disruptive Innovation, Conferences, Patient Experience, Study Voices, 2020 Events, Clinical Trial Innovations, COVID-19, DPHARM

Brand-aids for Clinical Trial Engagement

By Danielle Frate, Art Director on Tue, Sep 15, 2020 | 5 min read

 

While the public’s awareness of clinical studies as avenues to receive the latest potential treatments, contribute to medical science, and benefit from added care and attention grows, the need to ensure that patients are aware of study opportunities is crucial. Clinical teams are no longer simply referring to their study based on its protocol title or number, but instead selecting a consumer-facing name accompanied by a logo or icon to identify it within the marketplace.

But a brand is more than just a logo – it’s a means to create a first impression with a desired audience. Gone are the days when brands were reserved for consumer products. The earlier you are able to establish a brand for your study, the greater the chance you will achieve positive recognition throughout all phases - and perhaps even set the stage for post-approval marketing.

Topics: Patient Engagement, Advertising, Creative, Branding

 
Subscribe To Our Blog